A comprehensive scientific review has examined curcumin-integrated polymeric and hybrid composite systems, focusing on the direct relationships connecting carrier architecture, physicochemical properties, release mechanisms, and overall biomedical performance. Published in Polymer Bulletin, the review critically evaluates how specific structural strategies—notably drug-carrier interactions, covalent conjugation, and nanoscale confinement—act to regulate curcumin stability, encapsulation capacity, and release kinetics across advanced drug delivery platforms.
The survey encompasses a broad range of material categories, examining synthetic polymers, polysaccharide matrices, and protein-based carriers alongside polymer–inorganic nanohybrids, framework-structured composites, and metal–organic frameworks. By analyzing these varied architectures, the authors detail how compositional choices influence molecular encapsulation and release behavior, emphasizing that the physical construction of each matrix plays a fundamental role in controlling the stability and confinement of the active compound.
Across the selected formulations analyzed in the literature, reported particle dimensions range from approximately 110 to 400 nanometers. Furthermore, these composite systems achieve encapsulation efficiencies between 83 percent and 99.9 percent, paired with sustained drug release extending up to 72 hours. However, the evaluation explicitly highlights that these quantitative performance metrics are not universal, as observed particle sizes, loading efficiencies, and release durations depend heavily on specific formulation compositions and distinct preparation conditions.
The review investigates diverse potential biomedical applications for these composite systems, discussing anticancer, antimicrobial, anti-inflammatory, and wound-healing therapies alongside developments in tissue engineering, targeted delivery, phototherapy, bioimaging, and theranostics. In evaluating these therapeutic avenues, the paper also examines critical translational aspects, including material biosafety, biodegradation pathways, biological fate, and prominent clinical translation barriers that currently confront hybrid composite technologies.
Despite notable formulation-specific advances, the authors caution that achieving improved encapsulation efficiencies and sustained drug release alone does not establish therapeutic efficacy or ensure long-term biological safety. To successfully advance curcumin-integrated polymeric and hybrid composite systems toward real-world biomedical applications, the review concludes that researchers must establish standardized material characterization, rigorous comparative evaluations, formulation-specific toxicological assessments, and dependable pharmacokinetic and biological evidence.
Subject of Research: Curcumin-integrated polymeric and hybrid composite drug delivery systems
Article Title: Curcumin-integrated polymeric and hybrid composite systems for advanced drug delivery: design, structure–property relationships, and biomedical applications
Article References: Shrimali, I., Sharma, L., Sharma, S., Kour, M., Jadoun, S., Seifalian, A. M., & Chauhan, N. P. S. (2027). Curcumin-integrated polymeric and hybrid composite systems for advanced drug delivery: design, structure–property relationships, and biomedical applications. Polymer Bulletin, 84(1), Article 50. https://doi.org/10.1007/s00289-026-06805-8
Image Credits: AI Generated
DOI: 10.1007/s00289-026-06805-8
Keywords: curcumin, polymeric carriers, hybrid composites, drug delivery systems, nanoscale confinement, covalent conjugation, synthetic polymers, polysaccharide matrices, protein-based carriers, metal-organic frameworks, polymer-inorganic nanohybrids, encapsulation efficiency, sustained release, targeted delivery, theranostics, biosafety, pharmacokinetics
News Source: Neil Sanderson. (November 21, 2026). Curcumin Polymer Carriers Require Rigorous Biological Evidence Beyond Controlled Release. Scienmag.



